BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 16909210)

  • 1. Hepatocyte growth factor differently influences Met-E-cadherin phosphorylation and downstream signaling pathway in two models of breast cells.
    Matteucci E; Ridolfi E; Desiderio MA
    Cell Mol Life Sci; 2006 Sep; 63(17):2016-26. PubMed ID: 16909210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between human-breast cancer metastasis and bone microenvironment through activated hepatocyte growth factor/Met and beta-catenin/Wnt pathways.
    Previdi S; Maroni P; Matteucci E; Broggini M; Bendinelli P; Desiderio MA
    Eur J Cancer; 2010 Jun; 46(9):1679-91. PubMed ID: 20350802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SKI-606 decreases growth and motility of colorectal cancer cells by preventing pp60(c-Src)-dependent tyrosine phosphorylation of beta-catenin and its nuclear signaling.
    Coluccia AM; Benati D; Dekhil H; De Filippo A; Lan C; Gambacorti-Passerini C
    Cancer Res; 2006 Feb; 66(4):2279-86. PubMed ID: 16489032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine residues 654 and 670 in beta-catenin are crucial in regulation of Met-beta-catenin interactions.
    Zeng G; Apte U; Micsenyi A; Bell A; Monga SP
    Exp Cell Res; 2006 Nov; 312(18):3620-30. PubMed ID: 16952352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAP kinase and beta-catenin signaling in HGF induced RPE migration.
    Liou GI; Matragoon S; Samuel S; Behzadian MA; Tsai NT; Gu X; Roon P; Hunt DM; Hunt RC; Caldwell RB; Marcus DM
    Mol Vis; 2002 Dec; 8():483-93. PubMed ID: 12500177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative effect of hepatocyte growth factor and fibronectin in anchorage-independent survival of mammary carcinoma cells: requirement for phosphatidylinositol 3-kinase activity.
    Qiao H; Saulnier R; Patryzkat A; Rahimi N; Raptis L; Rossiter J; Tremblay E; Elliott B
    Cell Growth Differ; 2000 Feb; 11(2):123-33. PubMed ID: 10714768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast tumor kinase and extracellular signal-regulated kinase 5 mediate Met receptor signaling to cell migration in breast cancer cells.
    Castro NE; Lange CA
    Breast Cancer Res; 2010; 12(4):R60. PubMed ID: 20687930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear localization of active HGF receptor Met in aggressive MDA-MB231 breast carcinoma cells.
    Matteucci E; Bendinelli P; Desiderio MA
    Carcinogenesis; 2009 Jun; 30(6):937-45. PubMed ID: 19357348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion.
    Menakongka A; Suthiphongchai T
    World J Gastroenterol; 2010 Feb; 16(6):713-22. PubMed ID: 20135719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Src/histone deacetylase 3 interaction is crucial for hepatocyte growth factor dependent decrease of CXCR4 expression in highly invasive breast tumor cells.
    Matteucci E; Ridolfi E; Maroni P; Bendinelli P; Desiderio MA
    Mol Cancer Res; 2007 Aug; 5(8):833-45. PubMed ID: 17699109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HGF and TGFβ1 differently influenced Wwox regulatory function on Twist program for mesenchymal-epithelial transition in bone metastatic versus parental breast carcinoma cells.
    Bendinelli P; Maroni P; Matteucci E; Desiderio MA
    Mol Cancer; 2015 Jun; 14():112. PubMed ID: 26041563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M; Li Z; Marreli M; Nguyen BT; Park M; Wong K
    Cell Growth Differ; 1997 Apr; 8(4):451-62. PubMed ID: 9101091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Met receptor signaling: a key effector in esophageal adenocarcinoma.
    Anderson MR; Harrison R; Atherfold PA; Campbell MJ; Darnton SJ; Obszynska J; Jankowski JA
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):5936-43. PubMed ID: 17062664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of c-met in oral SCC promotes hepatocyte growth factor-induced disruption of cadherin junctions and invasion.
    Murai M; Shen X; Huang L; Carpenter WM; Lin CS; Silverman S; Regezi J; Kramer RH
    Int J Oncol; 2004 Oct; 25(4):831-40. PubMed ID: 15375530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
    Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
    Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocyte growth factor induces Wnt-independent nuclear translocation of beta-catenin after Met-beta-catenin dissociation in hepatocytes.
    Monga SP; Mars WM; Pediaditakis P; Bell A; Mulé K; Bowen WC; Wang X; Zarnegar R; Michalopoulos GK
    Cancer Res; 2002 Apr; 62(7):2064-71. PubMed ID: 11929826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lysophosphatidic acid modulates c-Met redistribution and hepatocyte growth factor/c-Met signaling in human bronchial epithelial cells through PKC delta and E-cadherin.
    Zhao Y; He D; Stern R; Usatyuk PV; Spannhake EW; Salgia R; Natarajan V
    Cell Signal; 2007 Nov; 19(11):2329-38. PubMed ID: 17689924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced expression of Wnt-1 and E-cadherin, and diminished beta-catenin stability in MCF-7 breast cancer cells that overexpress protein kinase C-alpha.
    Williams CL; Noti JD
    Int J Oncol; 2001 Dec; 19(6):1227-33. PubMed ID: 11713593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: cooperation between src and HGF/Met in invasion.
    Empereur S; Djelloul S; Di Gioia Y; Bruyneel E; Mareel M; Van Hengel J; Van Roy F; Comoglio P; Courtneidge S; Paraskeva C; Chastre E; Gespach C
    Br J Cancer; 1997; 75(2):241-50. PubMed ID: 9010033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional analysis of HGF/MET signaling and aberrant HGF-activator expression in diffuse large B-cell lymphoma.
    Tjin EP; Groen RW; Vogelzang I; Derksen PW; Klok MD; Meijer HP; van Eeden S; Pals ST; Spaargaren M
    Blood; 2006 Jan; 107(2):760-8. PubMed ID: 16189274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.